Implantable transducer devices
View Patent ↗Receiver-stimulators comprise a nearly isotropic transducer assembly, demodulator circuitry, and at least two tissue contacting electrodes. Use of near isotropic transducers allows the devices to be implanted with less concern regarding the orientation relative to an acoustic energy source. Transducers or transducer elements having relatively small sizes, typically less than ½ the wavelength of the acoustic source, enhance isotropy. The use of single crystal piezoelectric materials enhance sensitivity.
1. An implantable receiver-stimulator device comprising:
a transducer assembly which receives acoustic energy from an acoustic transmitter and produces electrical energy in response to the acoustic energy, wherein the electrical energy is characterized by a source impedance;
circuitry which receives the electrical energy and produces a biologically stimulating electrical output; and
at least two tissue contacting electrodes which receive the stimulating electrical output and deliver electrical energy to tissue, characterized by a tissue load impedance, wherein the source impedance and the tissue load impedance are matched.
2. The device of claim 1 , further comprising a demodulator circuitry.
3. The device of claim 2 , wherein the demodulator circuitry is configured for a 40-100% match between the source impedance and the tissue load impedance.
4. The device of claim 3 , wherein the match is 100%.
5. The device of claim 2 , wherein the transducer assembly comprises a plurality of individual transducer elements and wherein the demodulator circuitry further comprises a plurality of individual demodulator circuits, with the electrical energy from each transducer element fed to a demodulator circuit which produces a demodulator output, further comprising a summing circuitry which sums all of the demodulator outputs from all of the demodulator circuits to produce the biologically stimulating electrical output.
6. The device of claim 5 , wherein the demodulator outputs are summed in parallel.
7. The device of claim 5 , wherein the demodulator outputs are summed in series.
8. The device of claim 5 , wherein the demodulator outputs are summed in a series-parallel combination.
9. The device of claim 5 , wherein the transducer elements each have a size less than one-half the wavelength of an acoustic source while collectively having a size greater than one wavelength in any lateral dimension.
10. The device of claim 5 , further comprising a transformer between a transducer element and a demodulator circuit configured to match the source and tissue load impedances.
11. The device of claim 5 , further comprising a transformer between one or more demodulator circuits and the tissue electrodes configured to match the source and tissue load impedances.
12. The device of claim 1 , wherein the transducer assembly is composed of piezoelectric transducer material with specific impedance characteristics.
13. The device of claim 12 , comprising a shell having a wall surrounding an interior volume, wherein the transducer assembly and circuitry are within the interior volume and wherein at least a portion of the wall is acoustically transmissive.
14. The device of claim 13 , wherein the entire shell is acoustically transmissive.
15. The device of claim 14 , wherein the shell is cylindrical.
16. The device of claim 15 , wherein the shell has a diameter less than 5.0 mm and a length less than 20.0 mm.
17. The device of claim 16 , wherein the shell has a diameter less than 3.0 mm and a length less than 10.0 mm.
18. The device of claim 1 , further comprising a transformer configured to match the source and tissue load impedances.